Are fluoxetine’s effects due to sigma-1 receptor agonism?
- 1 November 2016
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 113, 707-708
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?Pharmacological Research, 2016
- High‐affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitisBritish Journal of Pharmacology, 2014
- Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s DiseaseNeuropsychopharmacology, 2013
- Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in ratsBrain Research Bulletin, 2011